Home/Filings/4/A/0001209191-21-049053
4/A//SEC Filing

Wu Sophia 4/A

Accession 0001209191-21-049053

CIK 0001777921other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 4:05 PM ET

Size

14.0 KB

Accession

0001209191-21-049053

Insider Transaction Report

Form 4/AAmended
Period: 2021-07-01
Wu Sophia
Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2021-07-01+168,117168,117 total(indirect: By Spouse)
  • Award

    Stock Option (right to buy)

    2021-07-01+38,02538,025 total
    Exercise: $1.59Exp: 2028-09-02Common Stock (38,025 underlying)
  • Award

    Stock Option (right to buy)

    2021-07-01+28,52628,526 total
    Exercise: $1.59Exp: 2029-01-10Common Stock (28,526 underlying)
  • Award

    Stock Option (right to buy)

    2021-07-01+217,284217,284 total
    Exercise: $3.90Exp: 2030-08-12Common Stock (217,284 underlying)
Footnotes (6)
  • [F1]Received on July 1, 2021 pursuant to that certain Business Combination Agreement and Plan of Reorganization ("BCA"), dated as of November 23, 2020, as amended on December 30, 2020, March 8, 2021 and May 18, 2021, by and among Apex Technology Acquisition Corporation ("Apex"), Athena Technology Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Apex, Athena Technology Merger Sub 2, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Apex and AvePoint, Inc. a Delaware corporation ("Former AvePoint") in exchange for Former AvePoint shares.
  • [F2]The BCA provides that the former stockholders of Former AvePoint will receive additional shares of the Issuer's Common Stock if the Issuer's closing share price equals or exceeds $12.50, $15.00 and $17.50 for any 20 trading days within any consecutive 30-trading day period prior to July 1, 2028. The Reporting Person's right to receive additional shares pursuant to this earn-out became fixed and irrevocable on July 1, 2021, the effective date of the merger.
  • [F3]These shares are held by the Reporting Person' spouse. The Reporting Person disclaims beneficial ownership with respect to the shares held by her spouse and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F4]25% of the shares underlying this option vested on September 3, 2019 and the remaining 75% of the shares underlying this option have vested or will vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service at each vesting date.
  • [F5]25% of the shares underlying this option vested on January 10, 2020 and the remaining 75% of the shares underlying this option have vested or will vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service at each vesting date.
  • [F6]25% of the shares underlying this option vest on August 12, 2021 and the remaining 75% of the shares underlying this option will vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service at each vesting date.

Issuer

AvePoint, Inc.

CIK 0001777921

Entity typeother

Related Parties

1
  • filerCIK 0001865562

Filing Metadata

Form type
4/A
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:05 PM ET
Size
14.0 KB